- CA$14.75m
- CA$6.42m
- $23.13m
- 91
- 75
- 48
- 82
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 11.3 | 17 | 28 | 19.7 | 23.1 |
Cost of Revenue | |||||
Gross Profit | 7.29 | 6.86 | 8.45 | 8.49 | 9.44 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 9.38 | 15.8 | 27.1 | 20.1 | 23.5 |
Operating Profit | 1.92 | 1.24 | 0.825 | -0.436 | -0.415 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.67 | 0.542 | 0.04 | -2.19 | -0.952 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.32 | 0.648 | -0.277 | -2.23 | -0.944 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.32 | 0.648 | -0.277 | -2.23 | -0.944 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.32 | 0.648 | -0.277 | -2.23 | -0.944 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.049 | 0.011 | -0.004 | -0.033 | -0.014 |